» Articles » PMID: 15133498

An Activated MTOR Mutant Supports Growth Factor-independent, Nutrient-dependent Cell Survival

Overview
Journal Oncogene
Date 2004 May 11
PMID 15133498
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

In yeast, TOR couples cellular growth and metabolism to the availability of extracellular nutrients. In contrast, mammalian TOR kinase activity has been reported to be regulated by growth factor stimulation via the PI3K/Akt pathway. Consistent with this, growth factor deprivation results in dephosphorylation of the mTOR target proteins p70S6k and 4EBP1 in the face of abundant extracellular nutrients. To determine whether the activation of mTOR was sufficient to support cell survival in the absence of other growth factor-mediated signal transduction, we evaluated the ability of a growth factor-independent mTOR mutant, DeltaTOR, to protect cells from growth factor deprivation. DeltaTOR- but not wild-type mTOR-expressing cells were protected from many of the sequelae of growth factor deprivation including amino-acid transporter degradation, reduction of the glycolytic rate, cellular atrophy, decreased mitochondrial membrane potential, and Bax activation. Furthermore, DeltaTOR expression increased growth factor-independent, nutrient-dependent cell survival and enhanced the ability of p53-/- MEFs to form colonies in soft agar. These results suggest that activating mutations of mTOR can contribute to apoptotic resistance and might contribute to cellular transformation.

Citing Articles

Glucose deprivation triggers DCAF1-mediated inactivation of Rheb-mTORC1 and promotes cancer cell survival.

Li M, Huang W, Zhang Y, Du Y, Zhao S, Wang L Cell Death Dis. 2024; 15(6):409.

PMID: 38862475 PMC: 11166663. DOI: 10.1038/s41419-024-06808-1.


The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization.

Liu Y, Zhang M, Jang H, Nussinov R Chem Sci. 2024; 15(3):1003-1017.

PMID: 38239681 PMC: 10793652. DOI: 10.1039/d3sc04690g.


Cryo-EM reconstructions of inhibitor-bound SMG1 kinase reveal an autoinhibitory state dependent on SMG8.

Langer L, Bonneau F, Gat Y, Conti E Elife. 2021; 10.

PMID: 34698635 PMC: 8592573. DOI: 10.7554/eLife.72353.


Identification and characterization of two novel oncogenic mTOR mutations.

Murugan A, Liu R, Xing M Oncogene. 2019; 38(26):5211-5226.

PMID: 30918329 PMC: 6597304. DOI: 10.1038/s41388-019-0787-5.


Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health.

Wipperman M, Montrose D, Gotto Jr A, Hajjar D Am J Pathol. 2019; 189(3):492-501.

PMID: 30803496 PMC: 6412382. DOI: 10.1016/j.ajpath.2018.11.013.